| Literature DB >> 29324224 |
Mihai Cirstea1, Nina Radisavljevic2, B Brett Finlay3.
Abstract
Our expanding knowledge of microbial mechanisms is challenging the notion of "good" versus "bad" microbes and encouraging a better understanding of their roles in various contexts before their widespread therapeutic and clinical application. The intestinal microbe Akkermansia muciniphila, a promising probiotic with an emerging cautionary tale, best highlights this challenge.Entities:
Mesh：
Year: 2018 PMID： 29324224 DOI： 10.1016/j.chom.2017.12.008
Source DB: PubMed Journal: Cell Host Microbe ISSN： 1931-3128 Impact factor: 21.023